Cited by — Author’s Response to: Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Author’s Response to: Nebulised Heparin for Lung Disease: Three Overlooked Risks that Merit Study Before Chronic Clinical Use.
No admitted local citation edges point to this work yet.
